New diabetes clinical trial: A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix

Published on: June 05, 2024 at 11:00PM
Conditions: Diabetic Foot Ulcer
Interventions: Device: Dermacyte Matrix; Other: Standard of Care (SOC)
Sponsors: Merakris Therapeutics
Not yet recruiting
https://ift.tt/hqSlzRV